J&J acquisition of Ambrx bolsters cancer ADC portfolio amidst big pharma’s growing investment trend: GlobalData Read more
Sanofi and Seagen announce collaboration to develop and commercialise multiple novel antibody-drug conjugates Read more
Kite and Shoreline Biosciences enter partnership to develop novel allogeneic cell therapies Read more